Sort
10,766 grants matching “checkpoint inhibitor”
Regulation of Genomic Instability in Early Breast Cancer
$77,298Thea D Tlsty · University Of California, San Francisco · R01 · FY2006 · CA
The frequency and function of Type 3 Innate Lymphoid Cells regulates the melanoma tumor microenvironment
$77,284Margaret O'Connor · Duke University · F32 · FY2024 · CA
SynerGel: A Novel Tumor Microenvironment-Modulating Hydrogel for Local Immunotherapy
$77,282Simon Young · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · DE
SynerGel: A Novel Tumor Microenvironment-Modulating Hydrogel for Local Immunotherapy
$77,282Simon Young · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · DE
Dual action immunostimulatory nanoparticles for treatment of aggressive cancers
$77,121Efstathios Karathanasis · Case Western Reserve University · R01 · FY2024 · CA
Pertussis inflammation is mediated by a balance between peptidoglycan recognition proteins-1 and -4
$77,108Ciaran Skerry · University Of Maryland Baltimore · R01 · FY2025 · AI
Pertussis inflammation is mediated by a balance between peptidoglycan recognition proteins-1 and -4
$77,108Ciaran Skerry · University Of Maryland Baltimore · R01 · FY2024 · AI
Immunobiology of Allogeneic Hematopoietic Cell Transplantation
$77,052Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · P01 · FY2021 · CA
Immune checkpoint abnormalities in human subjects with clonal hematopoiesis
$77,000Kim-Hien T Dao · Oregon Health & Science University · R03 · FY2018 · HL
Biology of major folate transporters and STING signaling in cancer
$77,000Zhanjun Hou · Wayne State University · R03 · FY2023 · CA
Biology of major folate transporters and STING signaling in cancer
$77,000Zhanjun Hou · Wayne State University · R03 · FY2022 · CA
Immune checkpoint abnormalities in human subjects with clonal hematopoiesis
$77,000Kim-Hien T Dao · Oregon Health & Science University · R03 · FY2019 · HL
Immune Checkpoint Regulation by the Integrated Stress Response Pathway in Lung Ca
$76,756Shayna Thomas-Jardin · Ut Southwestern Medical Center · F32 · FY2024 · CA
Combining Immunotherapy with Urolithin A to Improve Pancreatic Cancer Survival
$76,750Nagaraj S. Nagathihalli · University Of Miami School Of Medicine · R03 · FY2021 · CA
Silencing B7-H3 mitigates tumor aggressiveness in group 3 medulloblastoma
$76,750Sidharth Mahapatra · University Of Nebraska Medical Center · R03 · FY2025 · CA
Combining Immunotherapy with Urolithin A to Improve Pancreatic Cancer Survival
$76,750Nagaraj S. Nagathihalli · University Of Miami School Of Medicine · R03 · FY2020 · CA
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation
$76,725Cheryl A London · Tufts University Boston · U01 · FY2025 · CA
"Post-translational modification of non-histone proteins as a mechanism of pMHC-I neo-ligand generation"
$76,500Robert K. Bright · Texas Tech University Health Scis Center · R03 · FY2023 · CA
"Post-translational modification of non-histone proteins as a mechanism of pMHC-I neo-ligand generation"
$76,500Robert K. Bright · Texas Tech University Health Scis Center · R03 · FY2022 · CA
Role of Meis1 in Regulation of Cardiomyocyte Proliferation
$76,496Hesham Sadek · Ut Southwestern Medical Center · R01 · FY2014 · HL
Alterations in DNA Damage following Major Surgery and Hyperthermic Intraperitoneal Chemotherapy
$76,339Joseph Kim · University Of Kentucky · R03 · FY2022 · CA
Alterations in DNA Damage following Major Surgery and Hyperthermic Intraperitoneal Chemotherapy
$76,331Joseph Kim · University Of Kentucky · R03 · FY2023 · CA
Suppressors and drivers of long-tract repair DNA synthesis
$76,250Anna L Malkova · University Of Iowa · R03 · FY2019 · ES
The changing neoantigen landscape and associated immune response during immune checkpoint blockade in recurrent glioblastoma: a pathway to personalized tumor immunotherapy
$76,243Christina Jackson · Johns Hopkins University · F32 · FY2020 · NS
Development Project 2
$76,095Beti Thompson · Fred Hutchinson Cancer Research Center · U54 · FY2014 · CA